The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...
A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
New Clinical Indications Statement Expands Recommendations for Cardiac PET and Myocardial Blood Flow Quantification Based on the clinical and scientific evidence now available, there are no clinical ...
The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results